Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

NCT04086602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Cryopyrin Associated Periodic Syndrome

Interventions

DRUG: IZD334
DRUG: Placebos

Sponsor

Inflazome UK Ltd